Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SCHIZOPHRENIA 1 (Disorder)”

145 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 145 results

Not applicableUnknownNCT02916121
What this trial is testing

Potential Intervention Strategy With Folic Acid and Vitamin B12 in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Taipei Medical University WanFang Hospital 88
Not applicableStudy completedNCT00780585
What this trial is testing

A Follow up Safety Study of Patients Who Participated in Previous Studies of the Drug Org 24448 (Study P05719)(COMPLETED)

Who this might be right for
Psychosis
Merck Sharp & Dohme LLC 95
Early research (Phase 1)Study completedNCT01209039
What this trial is testing

A Repeat Dose Positron Emission Tomography Study With GSK1144814

Who this might be right for
Schizophrenia
GlaxoSmithKline 41
Not applicableStudy completedNCT02712463
What this trial is testing

Assess the Rate of Hospitalization in Participants With Schizophrenia Treated With Antipsychotics

Who this might be right for
Schizophrenia
Janssen-Cilag Ltd. 310
Post-approval studies (Phase 4)Study completedNCT02534363
What this trial is testing

Neurocognitive Effectiveness in Treatment of First-episode Non-affective Psychosis: 1-year Follow-up

Who this might be right for
SchizophreniaPsychotic Disorders
Fundación Marques de Valdecilla 136
Early research (Phase 1)Study completedNCT02935725
What this trial is testing

Assess the pharmacoMRI Effects of AUT00206 in Healthy Males

Who this might be right for
Schizophrenia
Autifony Therapeutics Limited 22
Not applicableNot Yet RecruitingNCT06817980
What this trial is testing

Disorders of the Sense of Self and Physical Activity

Who this might be right for
SCHIZOPHRENIA 1 (Disorder)Borderline Personality DisorderVestibular Syndromes
University Hospital, Strasbourg, France 168
Testing effectiveness (Phase 2)Study completedNCT00218218
What this trial is testing

Effects of Transdermal Nicotine on Smoking, Craving and Withdrawal in People With Schizophrenia

Who this might be right for
Schizophrenia and Disorders With Psychotic FeaturesTobacco Use DisorderSchizophrenia
National Institute on Drug Abuse (NIDA) 48
Large-scale testing (Phase 3)Study completedNCT00644969
What this trial is testing

Smoking Cessation Study for Patients With Schizophrenia or Schizoaffective Disorder

Who this might be right for
Smoking Cessation
Pfizer 128
Not applicableStudy completedNCT02050854
What this trial is testing

Open-Label Observational Pilot Study to Evaluate the Pharmacokinetics of Aripiprazole in Subjects With Bipolar 1 Disorder or Schizophrenia

Who this might be right for
Bipolar 1 DisorderSchizophreniaMental Disorder+1 more
Otsuka Pharmaceutical Development & Commercialization, Inc. 47
Not applicableStudy completedNCT02922400
What this trial is testing

Social Cognition Assessment in Young Adults

Who this might be right for
Cognitive Function 1, Social
The University of Texas at Dallas 153
Not applicableStudy completedNCT00528359
What this trial is testing

Β-Cell Function in Schizophrenic Subjects on Atypical Antipsychotic drugS

Who this might be right for
Schizophrenia
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 36
Early research (Phase 1)Ended earlyNCT02566759
What this trial is testing

A TAK-831-1001, Single and Multiple Rising Dose Study in Healthy Participants

Who this might be right for
Schizophrenia, Cerebellar Ataxia
Neurocrine Biosciences 110
Early research (Phase 1)Study completedNCT02748694
What this trial is testing

Phase 1 TAK-041 First-in-Human Safety, Tolerability, and Pharmacokinetics Study

Who this might be right for
Healthy VolunteersSchizophrenia
Neurocrine Biosciences 114
Early research (Phase 1)Ended earlyNCT01900522
What this trial is testing

Safety and Tolerability of Multiple Doses of ITI-214 in Healthy Adults and in Adults With Stable Schizophrenia

Who this might be right for
Schizophrenia
Takeda 76
Large-scale testing (Phase 3)Study completedNCT00228462
What this trial is testing

Relapse Prevention, RoW: Study to Evaluate Prevention of Relapse in Patients in Stable Chronic Schizophrenia Receiving Either Seroquel or Placebo

Who this might be right for
Schizophrenia
AstraZeneca 197
Not applicableStudy completedNCT07497516
What this trial is testing

Mindfulness-Based Yoga in Schizophrenia

Who this might be right for
SCHIZOPHRENIA 1 (Disorder)
Tarsus University 91
Testing effectiveness (Phase 2)Study completedNCT02219009
What this trial is testing

Open-label Study to Assess Usability of the Medical Information Device #1 (MIND1) System in Adults With Schizophrenia On Oral Aripiprazole

Who this might be right for
SchizophreniaMental DisorderNervous System Diseases
Otsuka Pharmaceutical Development & Commercialization, Inc. 67
Testing effectiveness (Phase 2)Study completedNCT01163227
What this trial is testing

Effect of AQW051 on Cognitive Function in Patients With Chronic Stable Schizophrenia

Who this might be right for
Schizophrenia Disorders
Novartis Pharmaceuticals 57
Early research (Phase 1)Study completedNCT07305779
What this trial is testing

A Trial to Test the Effects of Other Drugs on SEP-380135 in Healthy Men and Women

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Development & Commercialization, Inc. 12
Load More Results